0000880771-17-000110.txt : 20170614 0000880771-17-000110.hdr.sgml : 20170614 20170614165313 ACCESSION NUMBER: 0000880771-17-000110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170612 FILED AS OF DATE: 20170614 DATE AS OF CHANGE: 20170614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Low Raymond Anthony CENTRAL INDEX KEY: 0001391388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 17911666 MAIL ADDRESS: STREET 1: 25 SHADOW TREE CT CITY: DANVILLE STATE: CA ZIP: 94506 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2017-06-12 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001391388 Low Raymond Anthony 950 TOWER ROAD, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 VP, Finance & Controller Common Stock 2017-06-12 4 M 0 1250 0 A 15536 D Restricted Stock Unit 2017-06-12 4 M 0 1250 0 D Common Stock 1250 21250 D Includes 773 shares purchased under the Issuer's Employee Purchase Plan on May 31, 2017. Granted under the Issuer's 2005 Equity Incentive Plan. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment. /s/ Wilson W. Cheung, Attorney-in-Fact For: Raymond A. Low 2017-06-14